Over the years, the polymerase chain reactions (PCR) technique revolutionized molecular microbiology and medical diagnostics, owing to its ability to copy and multiply specific target DNA molecules which allow diagnosing diseases quickly, accurately, and at lower cost.
As the spread of coronavirus across the global shows no sign of slowing down, public health agencies and hospitals are making viral molecular diagnostics - which was buffeted by significant shortages - increasingly available.
With several countries still struggling to meet unprecedented rise in demand, biotech companies are ramping up the production of real-time polymerase chain reaction (RT-PCR) kits and systems. The result is also likely to potentially raise the demand for cartridges for RT-PCR automatic systems.
RT-PCR systems require the use of single-disposable cartridges that hold the RT-PCR reagents and host the entire process. These cartridges are self-contained, minimize cross-contamination between samples, and remain a gold standard for RT-PCR automatic systems that automate and integrate sample preparation, nucleic acid extraction and amplification, and detection of target sequences using RT-PCR assays.
Considering the importance of molecular diagnostics for early diagnosis in life-threatening diseases, especially in the time of Covid-19 pandemic, the demand for cartridges for RT-PCR automatic systems is expected to be on a significant rise. Relatively less handling time of samples and reduced risk of cross contamination are further offering tailwinds to the market growth.
In the current scenario, demand for cartridges for RT-PCR automatic systems is gaining a significant boost from CDC (Centers for Disease Control and Prevention) rolling out PCR test kits to numerous cities.
In addition to accelerating the verification process, CDC is also providing public health laboratories with diagnostic tools before unauthorized commercial products and test kits become available at scale. This, in turn, acts as a growth catalyzer for cartridges for RT-PCR automatic systems market.
It is imperative to note that a sudden spike in demand is leading to shortages of swaps and reagents for sample collection kits and diagnostic tools and emerging as one of the roadblocks that hinder public health agencies’ ability to perform widespread testing.
In sequence, a number of health startups are beginning to market at-home sample collection kits and cartridge-based testing kits, while the lack of authorization from Food and Drug Administration have halted the sales of these products.
North America is expected to remain at the forefront of the real-time PCR systems market as well as the cartridges for RT-PCR automatic systems market. Emergence of U.S. as the most affected area of the Covid-19 pandemic is currently playing a significant role in the market growth, which is further propelled by increasing production of testing kits and presence of advanced healthcare system.
A number of market players are also launching innovative Covid-19 detection kits using technology based on tried-and-tested PCR.
In March 2020, Cepheid’s Xpert® Xpress SARS-CoV-2 received FDA Emergency Use Authorization (EUC) for a point-of-care Covid-19 diagnostic. The automated molecular test can provide rapid detection of the current pandemic in approximately 45 minutes with less than a minute required for preparing the sample.
It is performed on GeneXpert Instrument Systems that uses disposable cartridges which include a Sample Processing Control (SPC) and Probe Check Control (PCC). As FDA accelerates the review and authorization of novel diagnostics during the coronavirus pandemic, sales of cartridges for RT-PCR automatic systems are expected to grow strong going forward.
In a separate section, the report covers the competitive scenario of the cartridges for RT-PCR automatic systems market that offer in-depth profiling of leading market players wherein their new product launches, total revenue, regional footprint, and growth strategies have been detailed.
Some of the prominent players include Thermo Fisher Scientific, Fluidigm Corporation, QIAGEN, Danaher Corporation, Agilent Technologies, Hoffmann-La Roche AG, GE Healthcare, Bio-Rad Laboratories Inc., and Abbott Laboratories.
With the rapid spread of coronavirus across multiple countries and the FDA’s EUA for Cepheid’s Xpert® Xpress SARS-CoV-2, a growing number of companies are racing to launch effective products and do their part in combating the spread of Covid-19.
The report categorizes the cartridges for RT-PCR automatic systems market into four segments on the basis of sample type, application, end user, and region.
Cartridges for RT-PCR Automatic Systems Market Analysis by Sample Type
Cartridges for RT-PCR Automatic Systems Market Analysis by Application
Cartridges for RT-PCR Automatic Systems Market Analysis by End User
Regional Analysis of the Cartridges for RT-PCR Automatic Systems Market
Explore Similar Insights
Cartridges for RT-PCR Automatic Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
